News
Epidemiology, Pathophysiology, Diagnosis, and Treatment of Heart Failure in Patients with Diabetes
The proven benefit of one class of antidiabetic drugs – sodium-glucose cotransporter 2 inhibitors (SGLT2i; gliflozins) – in treating heart failure irrespective of diabetes presence, and their inclusion in therapeutic recommendations for heart failure with reduced ejection fraction of the left ventricle, brings to light unresolved questions regarding the link between diabetes and heart failure. A recently published article summarizes the current knowledge on the epidemiology and pathophysiological connection of these two diseases, as well as…
Subclinical Hypothyroidism Associated with the Use of Allopurinol? What the Results of a Large Multicenter Study Suggested
Does the emergence of resistance to cetuximab mean ineffectiveness of all anti-EGFR antibodies?
VIDEO: Antibiotic Treatment of Infections Caused by MDR Bacteria – Seminar Recording
Genetic Profiling Transforms the Diagnosis and Treatment of Cancer Diseases
Dosing of Enoxaparin in Morbidly Obese Patients
Is long-term treatment with ixekizumab sufficiently safe?
Do Asthma Bronchiale and COPD Represent a Risk Factor for Severe COVID-19 and Death?
Risk Factors for Renal Cancer Formation After Kidney Transplantation
Kidney Carcinoma – Key Facts About the Disease With the Highest Incidence Worldwide in the Czech Republic
Conferences
News from the world of medicine
All conferences
Popular this week
- Where did COVID come from? Are infected animals or a lab leak to blame for the pandemic?
- Target blood pressure values in heart failure
- BENIGN DERMATOSIS OF PENIS
- Hypercalcemia may be the first sign of multiple myeloma, but not only that
- Could Artificial Intelligence Help with Emergency Department Triage in the Future?